Does HIV Infection Alter Parkinson Disease?

Moulignier, Antoine; Gueguen, Antoine; Lescure, François-Xavier; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 70(2):129-136, October 1, 2015.

A Randomized, Double-blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir DF...

Clumeck, Nathan; Molina, Jean-Michel; Henry, Keith; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 65(3):e121-e124, March 1, 2014.

A Randomized Phase 3 Study Comparing Once-Daily Elvitegravir With Twice-Daily Raltegravir in Treatment-Experienced Subjects With HIV-1 infection: 96-Week Results

Elion, Richard; Molina, Jean-Michel; Ramón Arribas López, José; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 63(4):494-497, August 1, 2013.

Randomized Placebo-Controlled Study of the Safety, Tolerability, Antiviral Activity, and Pharmacokinetics of 10-Day Monotherapy With BMS-986001, a Novel HIV NRTI, in...

Cotte, Laurent; Dellamonica, Pierre; Raffi, Francois; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 63(3):346-354, July 1, 2013.

A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and...

Rockstroh, Jürgen K.; DeJesus, Edwin; Henry, Keith; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 62(5):483-486, April 15, 2013.

Efficacy and Safety of Rilpivirine (TMC278) Versus Efavirenz at 48 Weeks in Treatment-Naive HIV-1–Infected Patients: Pooled Results From the Phase 3 Double-Blind Randomized ECHO...

Cohen, Calvin J.; Molina, Jean-Michel; Cahn, Pedro; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 60(1):33-42, May 1, 2012.

Long-Term Efficacy and Safety of Raltegravir, Etravirine, and Darunavir/Ritonavir in Treatment-Experienced Patients: Week 96 Results From the ANRS 139 TRIO Trial

Fagard, Catherine; Colin, Céline; Charpentier, Charlotte; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 59(5):489-493, April 15, 2012.

Comparative RNA Quantification of HIV-1 Group M and Non-M With the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR Assays

Sire, Jean-Marie; Vray, Muriel; Merzouk, Mourad; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 56(3):239-243, March 1, 2011.

Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive...

Molina, Jean-Michel; Andrade-Villanueva, Jaime; Echevarria, Juan; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 53(3):323-332, March 1, 2010.

Incidence and Risk Factors of Thrombocytopenia in Patients Receiving Intermittent Antiretroviral Therapy: A Substudy of the ANRS 106-Window Trial

Bouldouyre, Marie-Anne; Charreau, Isabelle; Marchou, Bruno; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 52(5):531-537, December 2009.

Safety and Efficacy of Darunavir (TMC114) With Low-Dose Ritonavir in Treatment-Experienced Patients: 24-Week Results of POWER 3

Molina, Jean-Michel; Cohen, Calvin; Katlama, Christine; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 46(1):24-31, September 1, 2007.

A Once-Daily Lopinavir/Ritonavir-Based Regimen Provides Noninferior Antiviral Activity Compared With a Twice-Daily Regimen

Johnson, Margaret A; Gathe, Joseph C Jr; Podzamczer, Daniel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 43(2):153-160, October 1, 2006.

Structured Treatment Interruptions in Primary HIV-1 Infection: The ANRS 100 PRIMSTOP Trial

Hoen, Bruno; Fournier, Isabelle; Lacabaratz, Christine; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 40(3):307-316, November 1, 2005.